Back to Home
Free CE/CMEVideo

Cases and Conversations: Real-World Insights on Advances in the Management of Myeloproliferative Neoplasms: How the Experts Apply the Latest Developments to Clinical Practice

Release Date

January 7, 2026

Expiration Date

January 8, 2027

Credits

3.0 CME, NCPD

Specialties

General Oncology, Hematologic Cancer+2 more

Release Date: January 7, 2026

Expiration Date: January 7, 2027

Activity Overview

This educational activity is an archive of the live presentation held on December 5, 2025.

For more information about this educational activity, the faculty, and disclosures, please click here.

Target Audience

This educational activity is directed toward physicians, nurses, NPs/PAs, pharmacists, and other HCPs involved in the diagnosis and treatment of MPNs

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Evaluate recent clinical trial data for new and emerging strategies to treat patients with MPNs
  • Determine appropriate evidence-based treatment for patients with newly diagnosed and previously treated MPNs
  • Discuss considerations for the supportive care of patients with MPNs
  • Describe strategies to identify and manage toxicities associated with treatments for MPNs
Cases and Conversations: Real-World Insights on Advances in the Management of Myeloproliferative Neoplasms: How the Experts Apply the Latest Developments to Clinical Practice

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 3.0 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Geron, Incyte Corporation, PharmaEssentia, and Takeda.

Related Content

View All

Course

Cases and Conversations: Real-World Insights on Advances in the Management of Myeloproliferative Neoplasms: How the Experts Apply the Latest Developments to Clinical Practice

Create Account